Engineered CRISPR-Cas9 nucleases with altered PAM specificities.

Nature
Authors
Keywords
Abstract

Although CRISPR-Cas9 nucleases are widely used for genome editing, the range of sequences that Cas9 can recognize is constrained by the need for a specific protospacer adjacent motif (PAM). As a result, it can often be difficult to target double-stranded breaks (DSBs) with the precision that is necessary for various genome-editing applications. The ability to engineer Cas9 derivatives with purposefully altered PAM specificities would address this limitation. Here we show that the commonly used Streptococcus pyogenes Cas9 (SpCas9) can be modified to recognize alternative PAM sequences using structural information, bacterial selection-based directed evolution, and combinatorial design. These altered PAM specificity variants enable robust editing of endogenous gene sites in zebrafish and human cells not currently targetable by wild-type SpCas9, and their genome-wide specificities are comparable to wild-type SpCas9 as judged by GUIDE-seq analysis. In addition, we identify and characterize another SpCas9 variant that exhibits improved specificity in human cells, possessing better discrimination against off-target sites with non-canonical NAG and NGA PAMs and/or mismatched spacers. We also find that two smaller-size Cas9 orthologues, Streptococcus thermophilus Cas9 (St1Cas9) and Staphylococcus aureus Cas9 (SaCas9), function efficiently in the bacterial selection systems and in human cells, suggesting that our engineering strategies could be extended to Cas9s from other species. Our findings provide broadly useful SpCas9 variants and, more importantly, establish the feasibility of engineering a wide range of Cas9s with altered and improved PAM specificities.

Year of Publication
2015
Journal
Nature
Volume
523
Issue
7561
Pages
481-5
Date Published
2015 Jul 23
ISSN
1476-4687
URL
DOI
10.1038/nature14592
PubMed ID
26098369
PubMed Central ID
PMC4540238
Links
Grant list
DP1 GM105378 / GM / NIGMS NIH HHS / United States
R01 GM088040 / GM / NIGMS NIH HHS / United States
R01 GM107427 / GM / NIGMS NIH HHS / United States
DP1 GM105378 / DP / NCCDPHP CDC HHS / United States